STERIS plc (STE) Stock Analysis
Verdict: WATCH (do not buy)
Recurring service revenue and AST growth provide a defensive floor, but a 20% valuation premium to peers and heavy insider selling limit near-term upside.
Investment score: 58/100
Analysis as of
Is STERIS plc stock worth reviewing? AI model thesis
STERIS is a high-quality defensive play with strong margins, but current technical weakness and lack of earnings surprises warrant caution.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 70/100 (weight 15%)
- Technical Momentum: 40/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 68/100 (weight 15%)
STERIS plc opportunities and risks
What speaks for STE
- Applied Sterilization Technologies (AST) Expansion
What speaks against STE
- Heavy Insider Selling Pressure
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| STE | 27.2x | 3.6x | 17.0x | 44.2% | 13.2% | 4.6% |
| MDT | 21.6x | 2.8x | 13.5x | 61.9% | 13.0% | 5.4% |
| TRIB | n/a | 0.1x | n/a | 35.4% | -85.3% | -97.0% |
| Peer median | 10.6x | 1.5x | n/a | 48.7% | -36.2% | -45.8% |
Frequently asked questions about STERIS plc (STE)
Is STE stock a good investment?
The cached TradeMates AI model rates STERIS plc as WATCH (do not buy) with an investment score of 58/100. STERIS is a high-quality defensive play with strong margins, but current technical weakness and lack of earnings surprises warrant caution. This is algorithmic model output, not personal investment advice.
Is STE stock a buy?
The TradeMates model verdict for STE is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.